BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression.
Saved in:
| Title: | BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression. |
|---|---|
| Authors: | Chang YC; TMU Research Center of Cancer Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Huang WL; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.; Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University, Tainan, Taiwan., Su WC; Center of Applied Nanomedicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, College of Medicine and Hospital, National Cheng Kung University, Tainan, Taiwan., Leung E; Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, University of Auckland, Grafton, Auckland, New Zealand., Cheng FY; Department of Chemistry, College of Natural Science and Engineering, Chinese Culture University, Taipei, Taiwan., Cheung CHA; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan. |
| Source: | International journal of nanomedicine [Int J Nanomedicine] 2026 Apr 28; Vol. 21, pp. 588571. Date of Electronic Publication: 2026 Apr 28 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN: 1178-2013 (Electronic) Linking ISSN: 11769114 NLM ISO Abbreviation: Int J Nanomedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1178-2013 |
|---|---|
| DOI: | 10.2147/IJN.S588571 |
